ESC 365 - Metformin will remain the first option in oral treatment of diabetes

ESC Premium Access

Metformin will remain the first option in oral treatment of diabetes

Session: Cardio-diabetology alliance - The myth busters

Topic: Diabetes, dysglycaemia and metabolic syndrome

Speaker: Professor N. Sattar (Glasgow, GB)

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speaker

Professor Naveed Sattar

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)

43 presentations

4 followers

3 more presentations in this session

Metabolically healthy obese people will populate the earth

Speaker: Professor D. Gaita (Timisoara, RO)

Beta-blockers and diuretics are not neutral for metabolism

Speaker: Professor K. Ray (London, GB)

Cardiovascular mortality cannot be decreased by antidiabetic drugs

Speaker: Professor E. Standl (Munich, DE)

Access the full session

Cardio-diabetology alliance - The myth busters

Speakers: Professor N. Sattar, Professor D. Gaita, Professor K. Ray, Professor E. Standl

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources